Cargando…
Correction to: First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314275/ https://www.ncbi.nlm.nih.gov/pubmed/35467237 http://dx.doi.org/10.1007/s10792-022-02249-x |
| _version_ | 1784754282516447232 |
|---|---|
| author | Bernardi, Enrico Töteberg-Harms, Marc |
| author_facet | Bernardi, Enrico Töteberg-Harms, Marc |
| author_sort | Bernardi, Enrico |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9314275 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93142752022-07-27 Correction to: First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma Bernardi, Enrico Töteberg-Harms, Marc Int Ophthalmol Correction Springer Netherlands 2022-04-25 2022 /pmc/articles/PMC9314275/ /pubmed/35467237 http://dx.doi.org/10.1007/s10792-022-02249-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Bernardi, Enrico Töteberg-Harms, Marc Correction to: First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma |
| title | Correction to: First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma |
| title_full | Correction to: First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma |
| title_fullStr | Correction to: First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma |
| title_full_unstemmed | Correction to: First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma |
| title_short | Correction to: First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma |
| title_sort | correction to: first and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314275/ https://www.ncbi.nlm.nih.gov/pubmed/35467237 http://dx.doi.org/10.1007/s10792-022-02249-x |
| work_keys_str_mv | AT bernardienrico correctiontofirstandsecondtransscleralcyclophotocoagulationtreatmentsprovidesimilarintraocularpressureloweringefficacyinpatientswithrefractoryglaucoma AT totebergharmsmarc correctiontofirstandsecondtransscleralcyclophotocoagulationtreatmentsprovidesimilarintraocularpressureloweringefficacyinpatientswithrefractoryglaucoma |